Philips Medical Systems International apparently made a good impressionon visiting Chinese physicians during the 1990 Radiological Societyof North America conference. Authorities in the People's Republicof China ordered a second Philips T5 mid-field
Philips Medical Systems International apparently made a good impressionon visiting Chinese physicians during the 1990 Radiological Societyof North America conference. Authorities in the People's Republicof China ordered a second Philips T5 mid-field magnetic resonanceimaging scanner last month. The first T5 unit is scheduled fordelivery in May.
The Chinese do not express much interest in low-field MRI,said Ron F. Jongbloets, PMSI regional manager for China, HongKong and Southeast Asia. They are looking for mid-field scannersto operate in regular hospitals and high-field systems for universityfacilities, he said.
A research group of Chinese university-affiliated doctors selectedthe T5 as the best mid-field MRI system during the RSNA meetinglast November in Chicago, Jongbloets said.
The two MRI orders mark an important initial step for PMSIin the PRC. Philips has no MRI systems installed in that country,although eight of its computed tomography units are installed,Jongbloets said.
The MRI market is in its infancy in China. There are only about10 systems overall in the country, compared to about 300 CT scanners,he said.
The Chinese hope to develop indigenous MRI manufacturing capabilities.They already produce low-field 0.15-tesla permanent magnet MRIunits through a joint venture with Analogic of the U.S. (SCAN12/14/88), Jongbloets said.
PRC officials are also interested in producing 0.5-tesla MRIsystems. Philips is exploring possible forms of cooperation insuch an endeavor, he said.
Chinese authorities only release enough foreign exchange tofinance the importation of four MRI systems a year. PMSI has beenable to deal directly with hospitals, although central permissionis required for high-value medical equipment purchases, he said.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.